The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2019 | Translating myeloma genomics into treatment strategies
Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone Medical Center, New York, NY, and Marc Raab, MD, of Heidelberg University Medical Center, Heidelberg, Germany, discuss recent advances in myeloma genomics. They highlight the various mutations seen in early and late phases of myeloma and the challenge of making successful therapies which harness the influence of epigenetics as well as the microbiome’s influence on myeloma. This roundtable was recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.
